Moreover, as FFAR4 was found to be significantly elevated in human esophageal cancer cells [29] serving as a positive regulator of malignant transformation, it may appear as an attractive early biomarker of esophageal carcinogenesis—especially in patients with ERD and BE. This evidence concerns the gene FFAR4 and esophageal cancer.